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Background: Various types of multiple sclerosis (MS) related pain have been discussed. One concept is that
deafferentation secondary to lesions in the spino-thalamo-cortical network can cause central pain. However,
this hypothesis is somehow limited by a lack of a robust association between pain episodes and sites of lesion
location.
Objective:We tested the hypothesis that temporary tissue alterations in the thalamus that are not detectable
by conventional magnetic resonance imaging (T1w, FLAIR) can potentially explain a focal, paroxysmal central
pain episode of a patient with MS. For microstructural tissue assessment we employed ten longitudinal dif-
fusion tensor imaging (DTI) examinations.
Results:We could demonstrate an abnormal, unilateral temporary increase of the fractional anisotropy (FA) in
the thalamus contralateral to the affected body side. Before the pain episode and after pain relief the FA
reached completely normal values as seen in identically investigated age and gender matched 100 healthy
control subjects.
Conclusion: These ﬁndings suggest that: i.) frequently applied and quantitatively evaluated DTI could be used
as a sensitive imaging technique for detection of pathological processes associated with MS not detectable
with conventional imaging strategies, ii.) temporary pathological processes in the “normal-appearing” thal-
amus may explain waxing and waning symptoms like episodes of central pain, and iii.) cross-sectional case
examinations on (MS) patients with central pain should be performed to investigate how often thalamic al-
terations occur together with central pain.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.1. Introduction
Structural magnetic resonance imaging (MRI) is the most commonly
used neuro-radiological tool in addition to clinical and laboratory data for
diagnosis andmonitoring of multiple sclerosis (MS), and has emerged as
a key surrogate measure for treatment outcomes in clinical trials (Filippi
et al., 2012). BecauseMS has been classically regarded as an inﬂammato-
ry, demyelinating condition that primarily affects white matter (WM)
tracts, the main focus of conventional MRI lies usually on WM plaques
(lesions) that occur as signal hyperintensities on T2-weighted images.
However, recent studies provide growing evidence of gray matter (GM)
involvement in MS, e.g. GM atrophy having a predictive value for devel-
opment of MS after clinically isolated syndromes (CIS) (Batista et al.,estfälischeWilhelms University,
er, Germany. Tel.: +49 251 83
).
nc. Open access under CC BY-NC-SA lic2012; Ceccarelli et al., 2008; Houtchens et al., 2007; Khaleeli et al.,
2007; Mesaros et al., 2011; Neema et al., 2009; Rocca et al., 2010;
Vercellino et al., 2009; Zivadinov et al., 2012). It has been shown, for ex-
ample, that selective GM atrophy is relevant in patients with CIS who
convert early to MS (Calabrese et al., 2011).
Despite the fast-paced development of imaging techniques there is
still a lack of robust association between relapses, clinical symptoms,
and sites of lesion location (Svendsen et al., 2011). In addition, methods
to detect neurodegeneration or neuroprotection during the disease
course in daily practice or clinical studies are still limited.
The microscopic spatial sensitivity of diffusion tensor imaging (DTI)
might be one approach to bridge this gap due to its potential to quantita-
tively differentiate apparently normal brain tissue on conventional MRI
(T1w, T2w, FLAIR) into tissue with normal and conspicuous water diffu-
sion behavior (Deppe et al., 2007). DTI has recently been applied success-
fully to quantify structuralWMdisintegration in a neuroprotection study
(Duning et al., 2011) and is capable to detect functionally relevant
neurodegeneration even if conventional MRI is inconspicuous (Deppe et
al., 2008; Stubbe-Dräger et al., 2012; Duning et al., 2010). These quantita-
tive characteristics of DTI and the ability to detect functionally relevant
microscopic alterations in “normal appearing” brain tissue (Reilmann etense.
Fig. 1. Comparison of DTI (column 1) and FLAIR MRI (columns 2–4). The slices were taken on examination #8 (row 1), #9 (row 2), and #10 (row 3). The slice position of the FA
image almost corresponds to the FLAIR section shown in column 2. While the FA image taken on examination 9 demonstrates increased FA in the left thalamus (white circle) during
the episode of central pain, the corresponding FLAIR (column 2, row 2) appears completely inconspicuous. The three FLAIR slices include all lesions found in the patient's brain,
including brain stem and whole spinal cord. The latter was imaged separately.
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for longitudinal studies on neurodegeneration and neuroprotection. The
objective of the present study was to exploit this new imaging technique
to investigate the origin of a pain episode in a patient with multiple scle-
rosis considered as central pain and to test the hypothesiswhether the or-
igin is associated with WM/GM plaques.
2. Methods
2.1. Patient
In context of a pilot examination for a clinical trial study1 a
38-year-old female patient with early MS, diagnosed according to
revised McDonald criteria (Polman et al., 2011), was admitted for
MRI at 10 different time points (average inter-scan interval=
25.6 days +/−13.1 days SD, total interval=230 days), after obtaining
written informed consent. The background of the pilot study was to ex-
amine the reproducibility of DTI parameters onMS patients. The patient
presented with a ﬁrst relapse of sensory symptoms of the left body side1 The background of the pilot study and the reason for the 10 consecutive MRI exam-
inations was to examine the reproducibility of DTI parameters on MS patients. Similar
reproducibility examinations have been performed on healthy control subjects.in 2011 and was diagnosed with relapsing remitting multiple sclerosis
(RRMS) in 2012 according to McDonald criteria. At that time she
showed dissemination in space (Swanton et al., 2006) and time in addi-
tion to oligoclonal bands, 6 lymphocytes/μl and intrathecal IgG produc-
tion. This ﬁrst relapse was contralateral (left) to the episode of central
pain and sensory symptoms of the relapse described in the following.
Shewas treatedwith immunomodulation (interferonß 1a, onceweekly
i.m.) after the ﬁrst relapse, andwhen she entered the series of DTI scans
her expanded disability status scale (EDSS)was 2.0.Within the series of
imaging scans she developed an episode of central pain and abnormal
somatosensory and thermal sensations on the right hand side of her
body. These symptoms occurred and disappeared simultaneously. Since
this combination of symptoms developed over 2 days and remained
for >24 hwe considered this episode as a relapse according to the inter-
national accepted deﬁnition of MS relapses. In addition, sensory symp-
toms and central pain very well responded to steroid therapy.
2.2. Control subjects
To prove the speciﬁcity and to quantitatively compare estimated
diffusion parameters we compared the patient's data with data of
identical DTI examinations, i.e. same scanner, same MRI sequences,
same data analysis, of 100 well age matched healthy female control
Fig. 2. Time course of mean FA in the left and right thalamus ROI over the 10 MRI ex-
aminations. The used two regions of interest (ROI) outlining the thalamus are overlaid
to the employed FA template. The “outbreak” of thalamic FA occurred only in the left
thalamus on examination #9 during the clinical episode of central pain.
260 M. Deppe et al. / NeuroImage: Clinical 2 (2013) 258–262subjects (mean age 38.05 y, SD 6.6 y, range 28 y–48 y). These subjects
have been scanned in context of another, epidemiological study. The
local ethics committee approved all examinations.
2.3. MR imaging acquisition
The patient underwent the longitudinal series of 10 DTI examina-
tions in parallel to conventional imaging (T1w, FLAIR). All MRI scans
were performed on a 3.0 T scanner (Gyroscan Intera T30, Philips Medi-
cal Systems, Best, The Netherlands) using a transmit–receive head coil.
Slice orientation was reproduced as accurately as possible.
2.3.1. FLAIR
TE=120 ms, optimized for lesion detectability at 3.0 T (Bachmann et
al., 2006), TI=2600 ms, TR=11 s, slice thickness=2 mm, no gap,
FOV=230 mm×230 mm, image matrix=512×512, number of
slices=54, voxel dimensions (X, Y, Z)=0.449 mm×0.449 mm×2.5 mm.
2.3.2. DTI
Diffusionweighted imageswere acquired byusing single-shot SE echo
planar imaging (EPI)with 20 diffusion directions (two b-factors, 0 s/mm2
and 1000 s/mm2, TR=9.8 s/TE=95 ms, acquisition matrix=128×128,
voxel size=1.8 mm×1.8 mm×3.6 mm (reconstructed to 2.0 mm×
2.0 mm×2.0 mm for image processing), 2 averages, scanning time
7:46 min).
2.4. DTI data post-processing
All diffusion-weighted images were effectively corrected for eddy
currents and head movements using a recently developed algorithm
(Mohammadi et al., 2010) and a multi-contrast image registration
algorithm for the optimum spatial pre-processing of DTI data
(Mohammadi et al., 2012). The registration algorithm provided iterative
multi-contrast registration steps based on FA contrasts and b0 contrasts
(b=0 s/mm2). Prior to the iterative registration, the b0 EPI imageswere
registered to the SPM EPI template using afﬁne transformations. The
multi-contrast registration was then iteratively applied to obtain nor-
malized FA images. In addition to the FA we generated whole-brain
maps of axial diffusivity (AD), radial diffusivity (RD), andmean diffusiv-
ity (MD). All registered diffusivity images corresponded to the MNI
coordinate space. For quantitative analysis of the optimally spatially
registered images, we generated ROIs for the left and right thalamus
separately, fromwhich mean values of FA, AD, RD, and MDwere calcu-
lated (Fig. 2). These ROIs were automatically created on the output im-
ages from the registration toolbox for all patients and controls. All DTI
image-processing steps (registration, eddy current correction, tensor esti-
mation, diffusion parameter and ROI calculation) were performed in a
fully automated processing pipeline (“Münster Neuroimaging Evaluation
System” (EVAL)).
3. Results
During the longitudinal series of 10 MRI examinations, DTI #9
showed a remarkable obvious FA increase in the left thalamus (Fig. 1).
This increase was further quantitatively investigated by a ROI analysis
of thalamus FA in the 10 DTIs of the patient as well as in the 100 control
subjects (Figs. 2 and 3). In the left and right thalamus ROIs the 100 con-
trol subjects had a mean FA value of 0.267 (SD: 0.016; range: 0.225–
0.296; 95%-CI: 0.264–0.270, CV2=6.0%) and 0.265 (SD: 0.015; range:
0.231–0.304; 95%-CI: 0.262–0.268, CV=5.5%), respectively. The aver-
age FA over the ﬁrst 8 images of the patient was 0.265 (SD: 0.004;
range: 0.259–0.269; 95%-CI: 0.262–0.265, CV=1.5%) for the left and
0.262 (SD: 0.005; range: 0.256–0.271; 95%-CI: 0.258–0.266, CV=1.9%)2 CV=coefﬁcient of variation=ratio of the standard deviation to the mean (×100%).for the right thalamus (Fig. 3) and thus well within the 95% conﬁdence
intervals for normal left and right thalamus FA. In the 9th image, which
was acquired exactly during the clinical appearance of the episode of
central pain in the right hand side of the body, the FA in the left ROI
was increased signiﬁcantly by 28% and far beyond the range of normal
controls (FA(exam. #9, left)=0.339, pFAb0.00001) while the right thal-
amus FA remained completely normal (FA(exam. 9, right)=0.265, p=
0.69) (Figs. 1 and 2). After clinical amelioration the tenth DTI showed
again completely normal FA in left and right thalamus (left 0.266, p=
0.99; right 0.262, p=0.850). Left thalamusMDandADwere signiﬁcantly
increased in DTI #9 (+15.6%, pMDb0.05 and +25.4%, pADb0.005) rela-
tive to the other 9 examinations. RD of DTI #9 showed only a tendency
to increase (+9.9%, pRD=0.18). Of note, conventional imaging (FLAIR)
failed to detect a thalamic lesion.Whitematter lesions could be detected
on more superior FLAIR sections (Fig. 1, column 3 and 4). These lesions
remained stable over all 10 MRI examinations.
4. Discussion
Themain ﬁnding of the present case study is a temporary, localwater
diffusion affecting process in aMS patient's left thalamus that is correlat-
edwith an episode of central pain and sensory deﬁcits of the contralater-
al body side. Changes in FA, AD, RD, or MD maps reﬂect alterations in
local water diffusion but are not speciﬁc to any inﬂammatory or degen-
erative activity in the brain. Thus, they always must be interpreted in
context of the clinical signs and the diagnosis of the patient. It is plausible
(Chen et al., 2010; Quiton et al., 2010), but not a priori justiﬁed to as-
sume, that in the present case the thalamic alteration plays a causative
role. Potentially, the local diffusion change could be also a treatment ef-
fect. Up to now, the direct impact of corticosteroids on local tissue diffu-
sion properties is not systematically investigated. Thus it cannot entirely
be ruled out that the detected water diffusion alteration in the thalamus
is an effect of corticosteroids. For example, Anneken et al. described a
transient lesion in the splenium of an epilepsy patient that was relat-
ed to antiepileptic medication (Anneken et al., 2008). This “lesion”
disappeared in DTI as well as in conventional T1w and T2w images
after the abrupt reduction of carbamazepine tohalf of thepatient's regular
dose. However, in the present case it would be far-fetched to explain a di-
rectly related effect of (any)medication that acts only on the left thalamus
Fig. 3. Comparisons of thalamic left and right mean FA between the patient and 100 control subjects. Apart from one exception (left thalamus, exam. #9), the patient's thalamic FA
was completely in the normal range. Each round symbol represents the mean FA in left or right thalamus of one examined control subject.
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tomon- and offset and the spatial congruencywith the affected body side
support a temporary pathological process in the thalamus as amore plau-
sible explanation for the symptoms and DTI ﬁndings.
The thalamus plays not only a fundamental role in pain perception
but also in processing of temperature, itch, and touch. Assuming a caus-
ative role of the thalamus here, it would not be surprising that the
symptoms of central pain and sensory deﬁcits of the right body side oc-
curred and disappeared simultaneously after steroid treatment (Kim et
al., 2007; LaBuda et al., 2000; Nandi et al., 2003). However, based on this
interrelation it cannot be ruled out if actually both, the pain and the sen-
sory deﬁcits are caused by the thalamus.
Using voxel-basedmorphometry, previous studies suggest that tha-
lamic degeneration is prominent even in the early course of the disease
of RRMSand clinically isolated syndrome (CIS), and a direct relationship
between white matter lesions and thalamic atrophy in CIS patients has
been demonstrated recently (Henry et al., 2009). While decreased GMvolumes suggest the presence of irreversible neuronal degeneration,
microstructural tissue alterations as assessed by DTI can be interpreted
as both, irreversible degeneration like axonal damage or temporary tis-
sue alterations due to reversible processes like inﬂammation, edema or
temporary changes of the blood–brain barrier (BBB).
Although the interpretation of DTI diffusivity parameters in GM is
still a topic of debate, the massive FA increase in our patient was most
probably due to an increase in axonal diffusivity, i.e. higher water mo-
bility along the main diffusion direction and not due to restriction of
water mobility orthogonal to the main direction.
It could be shown also in a different study that DTI is able to detect
abnormalities in the thalamus of MS patients, even when convention-
al imaging techniques showed inconspicuous results (Tovar-Moll et
al., 2009). In this study by Tovar-Moll and colleagues 24 MS patients
showed higher thalamic FA and MD compared to 24 controls. The
authors reported that the thalamic MD increase explained 55% of
EDSS variance in their patients with RRMS. They also found a
262 M. Deppe et al. / NeuroImage: Clinical 2 (2013) 258–262trend between thalamic MD increase and the partial sensory score
of the EDSS.
In our report the patient showed outside the pain episode FA andMD
values in both thalami essentially equivalent to 100 age- and sex-matched
controls. Parallel to the episode of central pain in the right hand side of
the body, FA values of the contralateral left thalamus were increased by
28%, distinctly outside of the range of all 100 controls (Fig. 3, upper
panel). This ﬁnding ﬁts also to current hypotheses that central pain can
be an important symptom inMS,which is putatively caused by patholog-
ical alterations in the spinothalamic tract (Osterberg et al., 2005) or in the
spinothalamo-cortical network (Osterberg and Boivie, 2010).
A further, methodological point seems also noteworthy: the low
intra- and inter-individual coefﬁcients of variation of 1.9% and 5%, respec-
tively, demonstrate that thalamic FA can be estimated to be highly repro-
ducible by clinically suited DTI and a fully automated data processing
pipeline. Thus, routine diffusion weighted MRI could principally provide
sensitive structural markers for (pathological) tissue alterations not de-
tectable by other non-invasive techniques. The high intra-individual
reproducibility in combination with the low inter-individual variability
of thalamic FA suggests cross-sectional case series on (MS) patients
with central pain to investigate how frequent the thalamic alterations
shown here can be found in patients with central pain.
5. Conclusion
Weconclude from this report of a single case and100 control subjects,
that DTI offers a valuable and quantitative tool that might signiﬁcantly
add novel information to standard imaging techniques (T1w, FLAIR) in
multiple sclerosis. The potential to detect the lesion location in paroxys-
mal symptoms like in a clinical episode of central pain seems appealing
for the monitoring of the disease course; perhaps this technique might
also offer a promising metric as marker of treatment response. Indepen-
dent trials arewarranted to prove theseﬁndings in larger cohorts of (MS)
patients with central pain.
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